Blood Loss Measurement During Cesarean Delivery

Completed

Conditions studied: Pregnancy

In brief

The aim of this study is to assess the ability of the Triton Device to measure blood loss among women undergoing elective and non-elective cesarean delivery. This patient population often experiences significant blood loss during surgery, and measurements of surgical blood loss are often inaccurate.

Key facts

Study ID

NCT02667600

Run by

Alex James Butwick

People needed

61

Starts

2016-05-01

Expected to finish

2017-12-12

Last updated by the study team

2018-09-05

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• American Society of Anesthesiologists physical status class I-III
• undergoing Cesarean delivery under neuraxial anesthesia
• age between 18 and 50
• gestational age greater than or equal to 37 completed weeks
• all ethnicities

You may not qualify if…

• contraindication for epidural or spinal analgesia (bleeding diathesis, neuropathy, severe scoliosis, local anesthetic allergy)
• inability to adequately understand the consent form

Where it is running

• Lucille Packard Children's Hospital — Palo Alto, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.